An arsenic oxide in which arsenic and oxygen atoms are present in the ratio 2:3.
Chemical ID:
MESH:C006632
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Arsenic Trioxide results in decreased expression of and results in decreased phosphorylation of AKT1 protein; Phloretin inhibits the reaction [Arsenic Trioxide results in decreased expression of AKT1 mRNA]; trans-sodium crocetinate inhibits the reaction [Arsenic Trioxide results in decreased expression of and results in decreased phosphorylation of AKT1 protein]
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [Arsenic Trioxide results in decreased phosphorylation of AKT1 protein]; 4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of AKT1 protein]; [AKT1 protein co-treated with 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole] inhibits the reaction [Arsenic Trioxide results in decreased expression of MCL1 protein]; [Arsenic Trioxide co-treated with IFNA2 protein co-treated with Docosahexaenoic Acids co-treated with Emodin] results in decreased expression of AKT1 protein; [Arsenic Trioxide results in increased expression of BCL2L11 protein] which results in decreased phosphorylation of AKT1 protein; [aspartyl-glutamyl-valyl-aspartal results in decreased activity of CASP3 protein] inhibits the reaction [Arsenic Trioxide results in decreased phosphorylation of AKT1 protein]; [Bortezomib results in decreased activity of CBL protein] promotes the reaction [Arsenic Trioxide results in increased activity of AKT1 protein]; [Sirolimus co-treated with Arsenic Trioxide] results in decreased phosphorylation of AKT1 protein; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in decreased activity of AKT1 protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in decreased phosphorylation of AKT1 protein]; AKT1 mutant form promotes the reaction [Arsenic Trioxide results in increased cleavage of CASP3 protein]; AKT1 mutant form promotes the reaction [Arsenic Trioxide results in increased cleavage of CASP9 protein]; AKT1 protein affects the reaction [Arsenic Trioxide affects the localization of SLC2A1 protein]; AKT1 protein affects the reaction [Arsenic Trioxide results in increased expression of CCND1 protein]; AKT1 protein affects the reaction [Arsenic Trioxide results in increased expression of CDC6 protein]; AKT1 protein inhibits the reaction [Arsenic Trioxide results in decreased phosphorylation of GSK3B protein]; AKT1 protein inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of MAPK1 protein]; AKT1 protein inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of MAPK3 protein]; AKT1 protein promotes the reaction [Arsenic Trioxide results in increased expression of TGIF1 mRNA]; Arsenic Trioxide affects the reaction [temsirolimus results in increased phosphorylation of AKT1 protein]; Arsenic Trioxide inhibits the reaction [AKT1 protein binds to MAPK8IP1 protein]; Arsenic Trioxide inhibits the reaction [lonidamine results in increased phosphorylation of AKT1 protein]; Arsenic Trioxide inhibits the reaction [Sirolimus results in increased phosphorylation of AKT1 protein]; Arsenic Trioxide inhibits the reaction [TGFB1 protein results in increased phosphorylation of AKT1 protein]; Arsenic Trioxide promotes the reaction [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased phosphorylation of AKT1 protein]; Arsenic Trioxide promotes the reaction [AKT1 protein binds to PPP2CA protein]; Arsenic Trioxide promotes the reaction [Curcumin results in decreased phosphorylation of AKT1 protein]; Arsenic Trioxide promotes the reaction [tanespimycin results in decreased expression of AKT1 protein]; Arsenic Trioxide promotes the reaction [Tretinoin results in decreased expression of AKT1 protein]; Arsenic Trioxide results in decreased activity of and results in decreased expression of AKT1 protein; Arsenic Trioxide results in decreased phosphorylation of and results in decreased activity of AKT1 protein; Arsenic Trioxide results in increased phosphorylation of and results in increased activity of AKT1 protein; aspartyl-glutamyl-valyl-aspartal inhibits the reaction [Arsenic Trioxide promotes the reaction [AKT1 protein binds to PPP2CA protein]]; benzyloxycarbonyl-valyl-alanyl-aspartic acid inhibits the reaction [Arsenic Trioxide results in decreased expression of AKT1 protein]; Genistein inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of and results in increased activity of AKT1 protein]; MAPK8 protein affects the reaction [Arsenic Trioxide results in decreased phosphorylation of and results in decreased activity of AKT1 protein]; NSC 680410 promotes the reaction [Arsenic Trioxide results in decreased phosphorylation of AKT1 protein]; Okadaic Acid inhibits the reaction [Arsenic Trioxide promotes the reaction [AKT1 protein binds to PPP2CA protein]]; Okadaic Acid inhibits the reaction [Arsenic Trioxide results in decreased phosphorylation of AKT1 protein]; Palmitic Acid inhibits the reaction [Arsenic Trioxide results in decreased phosphorylation of AKT1 protein]; pyrazolanthrone inhibits the reaction [Arsenic Trioxide results in decreased phosphorylation of and results in decreased activity of AKT1 protein]; Rosiglitazone inhibits the reaction [Arsenic Trioxide results in decreased phosphorylation of AKT1 protein]; setanaxib inhibits the reaction [Arsenic Trioxide results in decreased phosphorylation of AKT1 protein]; tanespimycin promotes the reaction [Arsenic Trioxide results in decreased expression of AKT1 protein]; Taurine inhibits the reaction [Arsenic Trioxide results in decreased phosphorylation of AKT1 protein]; Tretinoin promotes the reaction [Arsenic Trioxide results in decreased expression of AKT1 protein]
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [Arsenic Trioxide results in decreased phosphorylation of AKT1 protein]; Arsenic Trioxide inhibits the reaction [AKT1 protein binds to PPARG protein]; Arsenic Trioxide inhibits the reaction [Glycerol results in increased phosphorylation of AKT1 protein]; Arsenic Trioxide promotes the reaction [Reserpine results in decreased phosphorylation of AKT1 protein]; Arsenic Trioxide results in increased expression of and results in increased phosphorylation of AKT1 protein; Genistein inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of AKT1 protein]; Taurine inhibits the reaction [Arsenic Trioxide results in decreased phosphorylation of AKT1 protein]
